Chinese Herbal Pieces is one of the three pillars of the Chinese medicine industry. In recent years, with the advancement of science and technology, a traditional formula of traditional Chinese medicine decoction pieces, after extraction, separation, concentration, drying, granulation, packaging and other production processes, a new formula of uniform specifications, uniform dose, uniform quality standards Medication - Chinese medicine formula granules have entered the market and become another backbone of China's traditional Chinese medicine industry.
According to the analysis of the economic operation of the pharmaceutical industry announced in the website of the Industry and Development Department of the National Development and Reform Commission in 2017, the main business income of pharmaceutical enterprises above designated size was 2,982.06 billion yuan in 2017, a year-on-year increase of 12.2%, and the growth rate was 2.3 percentage points higher than that in 2016. Among the sub-sectors, the fastest growing is the processing of traditional Chinese medicine decoction pieces. In 2017, the main business income reached 216.53 billion yuan, a year-on-year increase of 16.7%, and the growth rate was 4 percentage points higher than that of 2016.
Table 1: Performance of five listed pharmaceutical companies in 2017 (unit: 100 million yuan)
(Source: Listed company annual report)
At present, in the Chinese market, listed pharmaceutical companies with large-scale sales of traditional Chinese medicine decoction pieces or traditional Chinese medicine formula granules include Kangmei Pharmaceutical, Chinese Traditional Medicine, Hongri Pharmaceutical, Xiangxue Pharmaceutical, and Tailong Pharmaceutical. Kangmei Pharmaceutical is the leader of traditional Chinese medicine decoction pieces, while Chinese traditional medicine is the leading enterprise in the Chinese medicine formula pellet market. The two pharmaceutical companies' operating income in this field exceeded RMB 4 billion in 2016, and in 2017 they broke through the RMB 5 billion mark. .
Kangmei Pharmaceutical: Chinese medicine decoction revenue exceeded 6.1 billion yuan
In 2017, Kangmei Pharmaceutical's operating income was 26.477 billion yuan, a year-on-year increase of 22.34%. The main performance drivers are: the company has formed a complete layout of the big health industry layout and industrial system, seize the opportunity of industry change, and consolidate The leading position of traditional Chinese medicine decoction tablets, leveraging private medical policy dividends, deepening medical services, seizing the strategic highland of the big health industry, and promoting the brand promotion through the core value system. In 2017, the net profit attributable to shareholders of listed companies was 4.101 billion yuan, a year-on-year increase of 22.77%.
Figure 1: Operating income of each business segment of Kangmei Pharmaceutical in 2016-2017 (Unit: 100 million yuan)
(Source: Listed company annual report)
Electronic Lock Safe Box,Home Security Electronic Lock Box,Electronic Key Safes,Electronic Lock
Hebei Tiger Brand Group Jia Bao Cabinet Industry Co. LTD , https://www.cntigersafe.com